Medically reviewed by Doru Paul, MD Key Takeaways Peritoneal cancer is a rare cancer that starts in the thin tissue lining the abdomen.Symptoms often appear late and can include abdominal pain, ...

The association between residual tumor volume after primary cytoreduction and survival was less consistent in patients with low-grade serous ovarian carcinoma (LGSOC) compared with other histology ...

A new guideline from ASCO updates evidence-based recommendations on the use of neoadjuvant chemotherapy and interval cytoreduction versus primary cytoreductive surgery (PCS) and chemotherapy in ...

Adding hyperthermic intraperitoneal chemotherapy (HIPEC) with mitomycin C to surgery for locally advanced colorectal cancer (CRC) significantly reduced the risk of locoregional recurrence, the ...

Phase II Clinical Trial of Bevacizumab and Low-Dose Metronomic Oral Cyclophosphamide in Recurrent Ovarian Cancer: A Trial of the California, Chicago, and Princess Margaret Hospital Phase II Consortia ...

Liver is the most common site for distant metastasis in ovarian cancer, with a median overall survival of 11 months for affected patients. A new nomogram was developed using SEER data, identifying age ...

The significance of KRAS mutations in advanced ovarian cancers treated by multitargeted therapy in Thailand. Radical treatment with weekly cisplatin (wCDDP) plus concurrent radiotherapy (XRT) in ...